Tetra Bio-Pharma (OTC: TBPMF) Submits Request for Scientific Advice to Malta Medicines Authority
Tetra plans for global commercialization of QIXLEEF OTTAWA, ON / April 28, 2021 /Tetra Bio-Pharma Inc. (“Tetra” or the “Company“) (TSX:TBP)(OTCQB:TBPMF)(FRA:JAM1), a leader in cannabinoid-derived drug discovery and development announced today that it has submitted a request […]
